Katalog GES

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

The discovery of Streptomyces-produced streptomycin founded the age of tuberculosis therapy. Despite the subsequent development of a curative regimen for this disease, tuberculosis remains a worldwide problem, and the emergence of multidrug-resistant Mycobacterium tuberculosis has prioritized the... Full description

1st Person: Fontaine, Evelyne
Additional Persons: Borchers, Kai; Courtemanche, Gilles; Bauer, Armin; Kling, Angela; Lagrange, Sophie; König, Claudia; Hoffmann, Holger; Tyagi, Sandeep; Wenzel, Silke C; Almeida, Deepak V; Nuermberger, Eric; Grosset, Jacques H; Brönstrup, Mark; Bordon-Pallier, Florence; Lukat, Peer; Hammann, Peter; Ammerman, Nicole C; Herrmann, Jennifer; Zaburannyi, Nestor; Geslin, Michel; Kohlmann, Markus; Matter, Hans; Müller, Rolf; Klieber, Sylvie; Lair, Christine; Fraisse, Laurent; Gerlitz, Martin; Heinz, Dirk W; Barrio, María Belén; Sordello, Sylvie; Kurz, Michael
Source: in Science Vol. 348, No. 6239 (2015), p. 1106
More Articles
Type of Publication: Article
Language: English
Published: 2015
Online: http://www.ncbi.nlm.nih.gov/pubmed/26045430
  Search for full text

Similar Items

Cannot find similar records

Library Services

Search Options

Quick links